Outcomes of accelerated corneal collagen cross-linking in keratoconus
DOI:
https://doi.org/10.31288/oftalmolzh201831016Keywords:
keratoconus, corneal collagen, accelerated cross-linkingAbstract
Keratoconus (KC) is a degenerative noninflammatory disease of the cornea which is characterized be structural changes in the cornea which leads to progressive thinning and bulging in the central and/or peripheral part of the cornea and is accompanied by irregular astigmatism and significant vision impairment.
Today, keratoconus treatment is focused on a stage of disease development. At progressive KC stages (II-III), corneal collagen cross-linking is performed. At the present, a latest-generation unit (UV-X™2000, Avedro) is used to perform accelerated cross-linking, which allows for a threefold decrease of the procedure duration (to 10 minutes) compared to the standard protocol
Material and Methods. Corneal collagen cross-linking was performed in 71 patients (100 eyes).
Results. Accelerated corneal collagen cross-linking for keratoconus stages II-III made it possible to stabilize the pathological process in 100% of cases, based on 12 month follow-up. Keratoconus stabilization was accompanied by: a decrease of astigmatism by 1.4 D and of the corneal refractive power by 3.2D; an increase of the corneal thickness by 8.8 nm; an increase of UCVA and BCVA in 96.5% and 89.6% of cases, respectively; and recovery of normal corneal architectonics according to confocal biomicroscopy data. Subjectively, 64 patients (90%) noted the improvement in the vision quality and better tolerance to spectacles correction.
References
1.Bikbov M.M., Surkova V.K. Corneal collagen crosslinking for keratoconus. A review. Ophthalmology in Russia. 2014;11(3):13-19. https://doi.org/10.18008/1816-5095-2014-3-13-19
2.Birich T.A., Chekina A.Yu., Aksenova N.I. [Results of treatment in patients with keratoconus]. Oftalmologiia Belarusi. 2010;1(4). In Russian.
3.Ivanovskaia EV, Vit VV, Golovchenko VG. [Immune status in patients with various stages of keratoconus and keratoglobus]. Oftalmol Zh. 2000;5:40-4. In Russian.
4.Sevastiyanov EN, Gorskova EN, Ekgard VF. [Keratoconus (etiology, pathogenesis, medicinal treatment): textbook]. Chelyabinsk: UGMADO;2005.32p. In Russian.
5.Solodkova EG, Remesnikov IA. [Modern approaches in the treatment progressive keratectasia]. Prakticheskaia meditsina. 2012;4:75-9. In Russian.
6.Adel Alhayek, Pei-Rong Lu. Corneal collagen crosslinking in keratoconus and other eye disease. Int J Ophthalmol. 2015; 8(2): 407-418. doi: 10.3980/j.issn.2222-3959.2015.02.35
7.Croghale NS. Epidemiology of keratoconus. Indian J. Ophthalmol. 2013;61(8): 382-3. https://doi.org/10.4103/0301-4738.116054
8.Kymionis GD, Portaliou DM, Bouzoukis DI, Suh LH, Pallikaris AI, Markomanolakis M, Yoo SH. Herpetic keratitis with iritis after corneal crosslinking with riboflavin and ultraviolet A for keratoconus. J Cataract and Refract Surg. 2007;33(11):1982-4. https://doi.org/10.1016/j.jcrs.2007.06.036
9.Kohlhaas M, Spoerl E, Schilde T et al. Biomechanical evidence of the distribution of cross-links in corneas treated with riboflavin and ultraviolet A light. J Cataract Refract Surg. 2006;32(2):279-283. https://doi.org/10.1016/j.jcrs.2005.12.092
10.Macsai MS, Varley GA, Krachmer JH. Development of keratoconus after contact lens wear: Patient characteristic. Arch Ophthalmol. 1990;108(26):534-8. https://doi.org/10.1001/archopht.1990.01070060082054
11.Mazzotta C, Balestrazzi A, Traversi C, et al. Treatment of progressive keratoconus by riboflavin-UVA-induced cross-linking of corneal collagen; ultrastructural analysis by Heidelberg Retinal Tomograph II in vivo confocal microscopy in humans. Cornea. 2007;26:390-7. https://doi.org/10.1097/ICO.0b013e318030df5a
12.Meek KM, Tuft SJ, Huang Y et al. Changes in collagen orientation and dis-tribution in keratoconus corneas. Invest. Ophthalmol. Vis. Sci. 2005;46(6):1948-56. https://doi.org/10.1167/iovs.04-1253
13.Nowak DM, Gajecka M. The genetics of keratoconus. Мiddle East Afr. J. Ophthalmol. 2001;18(1):2-6. https://doi.org/10.4103/0974-9233.75876
14.Rabinowitz YS. Keratoconus. Surv Ophthalmol. 1998;42(4):297-319. https://doi.org/10.1016/S0039-6257(97)00119-7
15.Rebecca McQuaid, Cummings AB, Mrochen M. The theory and art of corneal cross-linking. Indian J Ophthalmol. 2013;Aug; 61(8):416-9. https://doi.org/10.4103/0301-4738.116069
16.Spoerl E, Huhle M, Seiler T. Induction of cross-links in corneal tissue. Exp. Eye Res. 1998;66:97-103. https://doi.org/10.1006/exer.1997.0410
17.Spoerl E, Seiler TJ. Techniques for stiffening the cornea. Refract. Surg. 1999;15:711-3.
18.Spoerl E, Mrochen M, Sliney D, Trokel S, Seiler T. Safety of UVA-riboflavin cross-linking of the cornea. Cornea. 2007;26:385 9. https://doi.org/10.1097/ICO.0b013e3180334f78
19.Sporl E, Huhle M, Kasper M, Seiler T. Increased rigidity of the cornea caused by intrastromal crosslinking. Ophthalmologe. 1997;94(12):902-6. https://doi.org/10.1007/s003470050219
20.Tsubota K, Mashima Y, Murata H, Sato N, Ogata T. Corneal epithelium in keratoconus. Cornea. 1995;14:77-83. https://doi.org/10.1097/00003226-199501000-00013
21.Wollensak G, Spoerl E, Seiler T. Riboflavin ultraviolet-A-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135:620 7. https://doi.org/10.1016/S0002-9394(02)02220-1
22.Wollensak G, Spoerl E, Seiler T. Stress-strain measurements of human and porcine corneas after riboflavin-ultraviolet-A-induced cross-linking. J Cataract Refract Surg. 2003;29(9):1780-5. https://doi.org/10.1016/S0886-3350(03)00407-3
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Г. И. Дрожжина, Л. Ф. Тройченко, В. А. Науменко, О. Н. Иванова, Е. В. Середа
This work is licensed under a Creative Commons Attribution 4.0 International License.
This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) that allows users to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author as long as they cite the source.
COPYRIGHT NOTICE
Authors who publish in this journal agree to the following terms:
- Authors hold copyright immediately after publication of their works and retain publishing rights without any restrictions.
- The copyright commencement date complies the publication date of the issue, where the article is included in.
DEPOSIT POLICY
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) during the editorial process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work with an acknowledgement of its initial publication in this journal.
- Post-print (post-refereeing manuscript version) and publisher's PDF-version self-archiving is allowed.
- Archiving the pre-print (pre-refereeing manuscript version) not allowed.
